Kainic acid-mediated excitotoxicity as a model for neurodegeneration

Molecular Neurobiology

Volumn 31, Issue 1-3, 2005, Pages 3-16

  Wang, Qun ^a   Yu, Sue ^b   Simonyi, Agnes ^b   Sun, Grace Y ^b   Sun, Albert Y ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

Antioxidant; Astrocyte; Excitotoxicity; Hippocampal neurodegeneration; Kainic acid; Microglia; Neuronal death; Oxidative stress; Resveratrol; Selective vulnerability

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA TOCOPHEROL; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; AMYLOID PRECURSOR PROTEIN; ANTIOXIDANT; ASCORBIC ACID; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; COMPLEMENT; CYCLOSPORIN A; GLUTAMATE RECEPTOR; IONOTROPIC RECEPTOR; KAINIC ACID; KAINIC ACID RECEPTOR; LIPOFUSCIN; PHOSPHOLIPASE A2 INHIBITOR; REACTIVE OXYGEN METABOLITE; RESVERATROL; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; APOPTOSIS; CALCIUM CELL LEVEL; CELL ACTIVATION; CONFERENCE PAPER; DEGENERATIVE DISEASE; DENTATE GYRUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG PENETRATION; GLIA CELL; HIPPOCAMPUS; HUMAN; INFLAMMATION; NERVE CELL NECROSIS; NERVE CELL STIMULATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN INDUCTION; STIMULATION;

EID: 20344388665     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/mn:31:1-3:003     Document Type: Conference Paper

References (84)

1. Jellinger K.A. and Stadelmann C. (2000) Mechanisms of cell death in neurodegenerative disorders. J. Neural. Transm. 59(Suppl.), 95-114.
2. Doble A. (1999) The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol. Ther. 81, 163-221.
3. Meldrum B.S. (2000) Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J. Nutr. 130, 1007S-1015S.
4. Sun A.Y. and Chen Y.M. (1998) Oxidative stress and neurodegenerative disorders. J. Biomed. Sci. 5, 401-414.
5. Coyle J.T. (1987) Kainic acid: insights into excitatory mechanisms causing selective neuronal degeneration. Ciba Found. Symp. 126, 186-203.
6. Bleakman D. and Lodge D. (1998) Neuropharmacology of AMPA and kainate receptors. Neuropharmacology 37, 1187-1204.
7. Sun A.Y., Cheng Y., and Sun G.Y. (1992) Kainic acid-induced excitotoxicity in neurons and glial cells. Prog. Brain Res. 94, 271-280.
8. Cheng Y. and Sun A.Y. (1994) Oxidative mechanisms involved in kainate-induced cytotoxicity in cortical neurons. Neurochem. Res. 19, 1557-1564.
9. Gluck M.R., Jayatilleke E., Shaw S., et al. (2000) CNS oxidative stress associated with the kainic acid rodent model of experimental epilepsy. Epilepsy Res. 39, 63-71.
10. Milatovic D., Gupta R.C., and Dettbarn W.D. (2002) Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain. Brain Res. 957, 330-337.
11. Candelario-Jalil E., Al-Dalain S.M., Castillo R., et al. (2001) Selective vulnerability to kainate-induced oxidative damage in different rat brain regions. J. Appl. Toxicol. 21, 403-407.
12. Dawson R., Jr., Beal M.F., Bondy S.C., et al. (1995) Excitotoxins, aging, and environmental neurotoxins: implications for understanding human neurodegenerative diseases. Toxicol. Appl. Pharmacol. 134, 1-17.
13. 1Berger R. and Gamier Y. (1999) Pathophysiology of perinatal brain damage. Brain Res. Brain Res. Rev. 30, 107-134.
14. Arundine M. and Tymianski M. (2003) Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34, 325-337.
15. Arundine M. and Tymianski M. (2004) Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 61, 657-668.
16. Shen W., Zhang C., and Zhang G. (2002) Nuclear factor kappaB activation is mediated by NMDA and non-NMDA receptor and L-type voltage-gated Ca(2+) channel following severe global ischemia in rat hippocampus. Brain Res. 933, 23-30.
17. Yin H.Z., Sensi S.L., Carriedo S.G., et al. (1999) Dendritic localization of Ca(2+)-permeable AMPA/kainate channels in hippocampal pyramidal neurons. J. Comp. Neurol. 409, 250-260.
18. Ogoshi F. and Weiss J.H. (2003) Heterogeneity of Ca2+-permeable AMPA/kainate channel expression in hippocampal pyramidal neurons: fluorescence imaging and immunocytochemical assessment. J. Neurosci. 23, 10,521-10,530.
19. Grooms S.Y., Opitz T., Bennett M.V., et al. (2000) Status epilepticus decreases glutamate receptor 2 mRNA and protein expression in hippocampal pyramidal cells before neuronal death. Proc. Natl. Acad. Sci. USA 97, 3631-3636.
20. Li S.Y., Ni J.H., Xu D.S., et al. (2003) Down-regulation of GluR2 is associated with Ca2+-dependent protease activities in kainate-induced apoptotic cell death in cultured rat hippocampal neurons. Neurosci. Lett. 352, 105-108.
21. Pellegrini-Giampietro D.E., Gorter J.A., Bennett M.V., et al. (1997) The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci. 20, 464-470.
22. Friedman L.K. (1998) Selective reduction of GluR2 protein in adult hippocampal CA3 neurons following status epilepticus but prior to cell loss. Hippocampus 8, 511-525.
23. Weiss J.H. and Sensi S.L. (2000) Ca2+-Zn2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration. Trends Neurosci. 23, 365-371.
24. Sun A.Y., Cheng Y., Bu Q., et al. (1992) The biochemical mechanisms of the excitotoxicity of kainic acid. Free radical formation. Mol. Chem. Neuropathol. 17, 51-63.
25. Candelario-Jalil E. and Sonia Leon O. (2003) Effects of nimesulide on kainate-induced in vitro oxidative damage in rat brain homogenates. BMC Pharmacol. 3, 7.
26. Wang Q., Yu S., Simonyi A., Rottinghaus G., Sun G.Y., and Sun A.Y. (2004) Resveratrol protects against neurotoxicity induced by kainic acid. Neurochem. Res., 29, 2105-2112.
27. Patel M. and Li Q.Y. (2003) Age dependence of seizure-induced oxidative stress. Neuroscience 118, 431-437.
28. Lei D.L., Yang D.L., and Liu H.M. (1996) Local injection of kainic acid causes widespread degeneration of NADPH-d neurons and induction of NADPH-d in neurons, endothelial cells and reactive astrocytes. Brain Res. 730, 199-206.
29. Yasuda H., Fujii M., Fujisawa H., et al. (2001) Changes in nitric oxide synthesis and epileptic activity in the contralateral hippocampus of rats following intrahippocampal kainate injection. Epilepsia 42, 13-20.
30. Brown G.C. and Borutaite V. (2001) Nitric oxide, mitochondria, and cell death. IUBMB Life 52, 189-195.
31. Michaelis E.K. (1998) Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity oxidative stress and aging. Prog. Neurobiol. 54, 369-415.
32. Malva J.O., Carvalho A.P., and Carvalho C.M. (1998) Kainate receptors in hippocampal CA3 subregion: evidence for a role in regulating neurotransmitter release. Neurochem. Int. 32, 1-6.
33. Araki T., Simon R.P., Taki W., et al. (2002) Characterization of neuronal death induced by focally evoked limbic seizures in the C57BL/6 mouse. J. Neurosci. Res. 69, 614-621.
34. Tomioka M., Shirotani K., Iwata N., et al. (2002) In vivo role of caspases in excitotoxic neuronal death: generation and analysis of transgenic mice expressing baculoviral caspase inhibitor, p35, in postnatal neurons. Brain Res. Mol. Brain Res. 108, 18-32.
35. Chen Z., Ljunggren H.G., Zhu S.W., et al. (2004) Reduced susceptibility to kainic acid-induced excitoxicity in T-cell deficient CD4/CD8(-/-) and middle-aged C57BL/6 mice. J. Neuroimmunol. 146, 33-38.
36. Schauwecker P.E. (2002) Modulation of cell death by mouse genotype: differential vulnerability to excitatory amino acid-induced lesions. Exp. Neurol. 178, 219-235.
37. Nishiyama K., Kwak S., Takekoshi S., et al. (1996) In situ nick end-labeling detects necrosis of hippocampal pyramidal cells induced by kainic acid. Neurosci. Lett. 212, 139-142.
38. Osaka H., McGinty A., Hoepken U.E., et al. (1999) Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration. Neuroscience 88, 1073-1082.
39. Liu W., Kato M., Itoigawa M., et al. (2001) Distinct involvement of NF-kappaB and p38 mitogen-activated protein kinase pathways in serum deprivation-mediated stimulation of inducible nitric oxide synthase and its inhibition by 4-hydroxynonenal. J. Cell. Biochem. 83, 271-280.
40. Faherty C.J., Xanthoudakis S., and Smeyne R.J. (1999) Caspase-3-dependent neuronal death in the hippocampus following kainic acid treatment. Brain Res. Mol. Brain Res. 70, 159-163.
41. Aschner M. (1998) Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology 19, 269-281.
42. Zhang W., Smith C., Howlett C., et al. (2000) Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1beta. J. Cereb. Blood Flow Metab. 20, 967-978.
43. Li W., Xia J., and Sun G.Y. (1999) Cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC): response to genistein and pyrrolidine dithiocarbamate. J. Interferon Cytokine Res. 19, 121-127.
44. Calabrese V., Copani A., Testa D., et al. (2000) Nitric oxide synthase induction in astroglial cell cultures: effect on heat shock protein 70 synthesis and oxidant/antioxidant balance. J. Neurosci. Res. 60, 613-622.
45. Akama K.T. and Van Eldik L.J. (2000) Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism. J. Biol. Chem. 275, 7918-7924.
46. Kyrkanides S., Moore A.H., Olschowka J.A., et al. (2002) Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Brain Res. Mol. Brain Res. 104, 159-169.
47. Dorandeu F., Pernot-Marino I., Veyret J., et al. (1998) Secreted phospholipase A2-induced neurotoxicity and epileptic seizures after intracerebral administration: an unexplained heterogeneity as emphasized with paradoxin and crotoxin. J. Neurosci. Res. 54, 848-862.
48. Wang J.H. and Sun G.Y. (2000) Platelet activating factor (PAF) antagonists on cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC). Neurochem. Res. 25, 613-619.
49. Xu J., Weng Y.I., Simonyi A., et al. (2002) Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes. J. Neurochem. 83, 259-270.
50. Xu J., Yu S., Sun A.Y., et al. (2003) Oxidant-mediated AA release from astrocytes involves cPLA(2) and iPLA(2). Free Radical Biol. Med. 34, 1531-1543.
51. Farooqui A.A., Yi Ong W., Lu X.R., et al. (2001) Neurochemical consequences of kainate-induced toxicity in brain: involvement of arachidonic acid release and prevention of toxicity by phospholipase A(2) inhibitors. Brain Res. Brain Res. Rev. 38, 61-78.
52. Farooqui A.A., Yang H.C., Rosenberger T.A., et al. (1997) Phospholipase A2 and its role in brain tissue. J. Neurochem. 69, 889-901.
53. Farooqui A.A., Ong W.Y., and Horrocks L.A. (2004) Neuroprotection abilities of cytosolic phospholipase A2 inhibitors in kainic acid-induced neurodegeneration. Curr. Drug Targets Cardiovasc. Haematol Disord. 4, 85-96.
54. Albers D.S. and Beal M.F. (2000) Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J. Neural. Transm. 59(Suppl.), 133-154.
55. Kim H.C., Bing G., Jhoo W.K., et al. (2002) Oxidative damage causes formation of lipofuscin-like substances in the hippocampus of the senescence-accelerated mouse after kainate treatment. Behav. Brain Res. 131, 211-220.
56. Ivy G.O., Roopsingh R., Kanai S., et al. (1996) Leupeptin causes an accumulation of lipofuscin-like substances and other signs of aging in kidneys of young rats: further evidence for the protease inhibitor model of aging. Ann. NY Acad. Sci. 786, 12-23.
57. Asha Devi S., Prathima S., and Subramanyam M.V. (2003) Dietary vitamin E and physical exercise: II. Antioxidant status and lipofuscin-like substances in aging rat heart. Exp. Gerontol. 38, 291-297.
58. Maddalena A., Papassotiropoulos A., Muller-Tillmanns B., et al. (2003) Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42. Arch. Neurol. 60, 1202-1206.
59. Rego A.C. and Oliveira C.R. (2003) Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem. Res. 28, 1563-1574.
60. Panegyres P.K. (1998) The effects of excitotoxicity on the expression of the amyloid precursor protein gene in the brain and its modulation by neuroprotective agents. J. Neural. Transm. 105, 463-478.
61. Shoham S. and Ebstein R.P. (1997) The distribution of beta-amyloid precursor protein in rat cortex after systemic kainate-induced seizures. Exp. Neurol. 147, 361-376.
62. Ong W.Y., He Y., and Garey L.J. (1997) Distribution of amyloid beta-protein immunoreactivity in the hippocampus of rats injected with kainate. J. Hirnforsch. 38, 353-361.
63. Louzada P.R., Jr., Paula Lima A.C., de Mello F.G., et al. (2001) Dual role of glutamatergic neurotransmission on amyloid beta(1-42) aggregation and neurotoxicity in embryonic avian retina. Neurosci. Lett. 301, 59-63.
64. Morimoto K. and Oda T. (2003) Kainate exacerbates beta-amyloid toxicity in rat hippocampus. Neurosci. Lett. 340, 242-244.
65. Harris K.A., Oyler G.A., Doolittle G.M., et al. (1993) Okadaic acid induces hyperphosphorylated forms of tau protein in human brain slices. Ann. Neurol. 33, 77-87.
66. Esclaire F., Lesort M., Blanchard C., et al. (1997) Glutamate toxicity enhances tau gene expression in neuronal cultures. J. Neurosci. Res. 49, 309-318.
67. Hugon J., Terro F., Esclaire F., et al. (2000) Markers of apoptosis and models of programmed cell death in Alzheimer's disease. J. Neural. Transm. 59(Suppl.), 125-131.
68. Esclaire F., Terro F., Yardin C., et al. (1998) Neuronal apoptosis is associated with a decrease in tau mRNA expression. Neuroreport 9, 1173-1177.
69. Hugon J., Esclaire F., Lesort M., et al. (1999) Toxic neuronal apoptosis and modifications of tau and APP gene and protein expressions. Drug Metab. Rev. 31, 635-647.
70. Verbeek M.M., Otte-Holler I., van den Born J., et al. (1999) Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. Am. J. Pathol. 155, 2115-2125.
71. van Horssen J., Otte-Holler I., David G., et al. (2001) Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. Acta Neuropathol. (Berl). 102, 604-614.
72. van Horssen J., Kleinnijenhuis J., Maass C.N., et al. (2002) Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol. Aging 23, 537-545.
73. Shee W.L., Ong W.Y., and Lim T.M. (1998) Distribution of perlecan in mouse hippocampus following intracerebroventricular kainate injections. Brain Res. 799, 292-300.
74. Yasojima K., Schwab C., McGeer E.G., et al. (1999) Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am. J. Pathol. 154, 927-936.
75. Lynch N.J., Willis C.L., Nolan C.C., et al. (2004) Microglial activation and increased synthesis of complement component C1q precedes blood-brain barrier dysfunction in rats. Mol. Immunol. 40, 709-716.
76. Fonseca M.I., Kawas C.H., Troncoso J.C., et al. (2004) Neuronal localization of C1q in preclinical Alzheimer's disease. Neurobiol. Dis. 15, 40-46.
77. Fan R. and Tenner A.J. (2004) Complement C1q expression induced by Abeta in rat hippocampal organotypic slice cultures. Exp. Neurol. 185, 241-253.
78. Sarvari M., Vago I., Weber C.S., et al. (2003) Inhibition of Clq-beta-amyloid binding protects hippocampal cells against complement mediated toxicity. J. Neuroimmunol. 137, 12-18.
79. Goldsmith S.K., Wals P., Rozovsky I., et al. (1997) Kainic acid and decorticating lesions stimulate the synthesis of C1q protein in adult rat brain. J. Neurochem. 68, 2046-2052.
80. Miller N.J. and Rice-Evans C.A. (1995) Antioxidant activity of resveratrol in red wine. Clin. Chem. 41, 1789.
81. Fremont L. (2000) Biological effects of resveratrol. Life Sci. 66, 663-673.
82. Sun A.Y., Simonyi A., and Sun G.Y. (2002) The "French Paradox" and beyond: neuroprotective effects of polyphenols. Free Radical Biol. Med. 32, 314-318.
83. Chanvitayapongs S., Draczynska-Lusiak B., and Sun A.Y. (1997) Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport 8, 1499-1502.
84. Draczynska-Lusiak B., Doung A., and Sun A.Y. (1998) Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease. Mol. Chem. Neuropathol. 33, 139-148.